2nd Quarter - Report
WALGREEN COMPANY for WALGREEN COMPANY
Firm
Client
Income
—
Expenses
$430,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to pharmacy provider status. H.R. 3554 / S. 1909; issues related to direct and indirect remuneration fees in Medicare. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMANTHA HELTON New | — |
| ALETHIA JACKSON | — |
| KATIE L SMITH New | — |
Consumer Issues/Safety/Products CSP
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMANTHA HELTON New | — |
| ALETHIA JACKSON | — |
| KATIE L SMITH New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.